Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02406 | Pages: NA | Charts: NA | Tables: NA |
The anastomosis is a surgical interrelation to unify the 2 tubular structures, like intestine loops or blood vessels. The anastomosis is carried out by surgeons while performing surgeries like gastrointestinal and heart surgeries using anastomosis devices where the surgeon staples open ends which help in the formation of connections. Anastomosis is an interrelation between two normally divergent structures which refers to connections between two blood vessels or between any tubular structures like loops of intestine. Anastomotic devices are proximal and lateral, can ease the creation of quick, reproducible, acquiescent anastomoses, pump, in potentially difficult-to-access areas, potentially with neuroprotective benefits, frequently through minimal-access incisions, and thus can reduce hazards intrinsic in manually constructing anastomoses in technically challenging or suboptimal situations. Gastrointestinal and vascular are the two major forms of anastomosis. In vascular anastomosis a connection is established between a blood vessel and a graft which helps in the creation of a bypass while a heart bypass surgery is being performed.
Contrarily, anastomosis for the gastrointestinal disorders is carried out during the surgery of bowel resection, where the surgeon staples the two edges of the intestine by using either staples or stitches. HEARTSTRING II Proximal Seal System, Enclose II Anastomosis Assist Device PAS-Port Proximal Anastomosis System, and C-Port Distal Anastomosis Systems are the major devices used to perform anastomosis in the market.
COVID-19 scenario analysis:
To take care of the infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With a rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil populations for precautionary measures. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.
Owing to such factors, COVID 19 is expected to have a significant impact on the Anastomosis devicemarket.
Increasing incidences of target diseases, succeeding growth in the number of surgeries, an increase in the demand for minimally invasive surgeries, and technological advancements like the development of anastomoses devices to reduce the risk related to manual anastomoses are the major factors impacting the anastomosis device market.
A growing number of cardiovascular surgical procedures been performed and also a rising prevalence of chronic diseases like gastrointestinal and cardiac disorders, around the globe are the factors that are driving the global anastomosis devices market. Moreover, technological advancement and favorable reimbursement scenario in cardiac procedures, which includes coronary artery bypass graft (CABG), angioplasty, open-heart valve replacement, in developed countries are boosting the anastomosis market. Rising demand of slightly invasive procedures for coronary artery bypass surgery, use of anastomosis devices in various other surgeries such as orthopedic, gynecological, ophthalmic surgeries and various benefits of anastomoses devices like stenosis, reducing chances of vessel leakage, and occlusion as compared to conventional procedures are one of the other factors expected to support the growth of the global anastomosis devices market.
On the other hand, difficulties associated with anastomosis like an anastomotic leak, the soaring cost of devices and the extensive clinical data need for launching new products are restraining the growth of anastomosis market.
On January 18th, 2019, Intuitive Surgical has receivedFDA approval for its SureForm 45 Stapler.
On March 19th, 2018, Baxter International Inc. acquired Mallinckrodt Pharmaceutical’s PREVELEAK Surgical Sealant and RECOTHROM Surgical Hemostat and Sealant Portfolio. This acquisition broadened Baxter’s portfolio of advanced surgical sealants.
The major end-users of anastomosis devices are hospitals and ambulatory surgery centers (ASCs) & clinics. Amongst them, hospitals have the highest consumption. Due to the increasing number of hospitals, growing patient preference for hospital treatment, and skilled healthcare professionals increasing availability & technologically advanced facilities.
Key benefits of the report:
Questions answered in the Anastomosis device Market research report:
Key Market Segments
Key Market Players
